Exide Industries FY26 Annual Earnings Summary

Lead prices remain elevated; management paused price hikes after GST cut, risking margin compression.

First-of-its-kind plant faces process stabilization and homologation delays; no firm off-take agreements disclosed.

Despite a 2% price hike in January, management could not fully pass on cost increases due to competitive pressures, risking margin compression if commodity prices remain elevated.

Sulfuric acid prices have risen 5x YoY, and lead prices remain volatile due to rupee depreciation. Management expects continued headwinds in H1 FY27.

Export business declined for second consecutive quarter due to tariff uncertainties; recovery uncertain.

Extended Producer Responsibility provisions increased other expenses in Q2; may not be fully passable to customers.

Management declined to provide specific margin guidance for the lithium-ion business, citing B2B pricing dynamics and import competition, creating uncertainty for investors.

Analyst raised concern about senior-level exits at Exide Energy Solutions; management acknowledged churn but downplayed impact, though succession planning may be tested.

Exports remain weak (5-6% of revenue) due to geopolitical tensions and tariff barriers; recovery hinges on favorable tariff announcements and new partner ramp-up.

Exports business declined due to West Asia conflict and global uncertainties, with management expecting these to persist at least in H1 FY27.

Analyst raised concerns about cell yields and pricing vs imports. Management acknowledged yield improvement takes time and current costs are higher than imports, but expects to match landed cost with scale and localisation.

Management noted that without government incentives for local cell manufacturing, investments may not be viable. Policy support is uncertain.